Literature DB >> 27856614

Next generation of small molecules in inflammatory bowel disease.

Pablo Olivera1,2, Silvio Danese3, Laurent Peyrin-Biroulet2.   

Abstract

Entities:  

Keywords:  CLINICAL TRIALS; CROHN'S DISEASE; DRUG DEVELOPMENT; ULCERATIVE COLITIS

Mesh：

Substances：

Year:  2016        PMID： 27856614     DOI： 10.1136/gutjnl-2016-312912

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  18 in total

Review 1.  [What rheumatologists can learn from gastroenterologists].

Authors:  S Fischer; C Beyer; M F Neurath
Journal:  Z Rheumatol       Date:  2018-08       Impact factor: 1.372

2.  Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease.

Authors:  Johannes P D Schultheiss; Remi Mahmoud; Jonas M Louwers; Michiel T van der Kaaij; Boris P van Hellemondt; Petra G van Boeckel; Nofel Mahmmod; Bindia Jharap; Herma H Fidder; Bas Oldenburg
Journal:  Aliment Pharmacol Ther       Date:  2021-09-24       Impact factor: 9.524

Review 3.  Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease.

Authors:  Bram Verstockt; Stefania Vetrano; Azucena Salas; Shadi Nayeri; Marjolijn Duijvestein; Niels Vande Casteele
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-02-14       Impact factor: 73.082

Review 4.  JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.

Authors:  Azucena Salas; Cristian Hernandez-Rocha; Marjolijn Duijvestein; William Faubion; Dermot McGovern; Severine Vermeire; Stefania Vetrano; Niels Vande Casteele
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-19       Impact factor: 46.802

Review 5.  Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease.

Authors:  Pavine L C Lefevre; Niels Vande Casteele
Journal:  J Crohns Colitis       Date:  2020-08-01       Impact factor: 9.071

Review 6.  Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors.

Authors:  Edoardo Troncone; Irene Marafini; Giovanna Del Vecchio Blanco; Antonio Di Grazia; Giovanni Monteleone
Journal:  Clin Exp Gastroenterol       Date:  2020-05-05

Review 7.  Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products.

Authors:  Karma Yeshi; Roland Ruscher; Luke Hunter; Norelle L Daly; Alex Loukas; Phurpa Wangchuk
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

Review 8.  Recent advances and emerging therapies in the non-surgical management of ulcerative colitis.

Authors:  Jan Wehkamp; Eduard F Stange
Journal:  F1000Res       Date:  2018-08-07

Review 9.  Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.

Authors:  Sun Young Moon; Kwang Dong Kim; Jiyun Yoo; Jeong-Hyung Lee; Cheol Hwangbo
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

10.  Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits.

Authors:  Luciano G Morosi; Anabela M Cutine; Alejandro J Cagnoni; Montana N Manselle-Cocco; Diego O Croci; Joaquín P Merlo; Rosa M Morales; María May; Juan M Pérez-Sáez; María R Girotti; Santiago P Méndez-Huergo; Betiana Pucci; Aníbal H Gil; Sergio P Huernos; Guillermo H Docena; Alicia M Sambuelli; Marta A Toscano; Gabriel A Rabinovich; Karina V Mariño
Journal:  Sci Adv       Date:  2021-06-18       Impact factor: 14.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.